Cyanotic congenital heart disease and atherosclerosis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Cyanotic congenital heart disease and atherosclerosis. / Tarp, Julie Bjerre; Jensen, Annette Schophuus; Engstrøm, Thomas; Holstein-Rathlou, Niels-Henrik; Søndergaard, Lars.

In: Heart, Vol. 103, 06.2017, p. 897-900.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Tarp, JB, Jensen, AS, Engstrøm, T, Holstein-Rathlou, N-H & Søndergaard, L 2017, 'Cyanotic congenital heart disease and atherosclerosis', Heart, vol. 103, pp. 897-900. https://doi.org/10.1136/heartjnl-2016-311012

APA

Tarp, J. B., Jensen, A. S., Engstrøm, T., Holstein-Rathlou, N-H., & Søndergaard, L. (2017). Cyanotic congenital heart disease and atherosclerosis. Heart, 103, 897-900. https://doi.org/10.1136/heartjnl-2016-311012

Vancouver

Tarp JB, Jensen AS, Engstrøm T, Holstein-Rathlou N-H, Søndergaard L. Cyanotic congenital heart disease and atherosclerosis. Heart. 2017 Jun;103:897-900. https://doi.org/10.1136/heartjnl-2016-311012

Author

Tarp, Julie Bjerre ; Jensen, Annette Schophuus ; Engstrøm, Thomas ; Holstein-Rathlou, Niels-Henrik ; Søndergaard, Lars. / Cyanotic congenital heart disease and atherosclerosis. In: Heart. 2017 ; Vol. 103. pp. 897-900.

Bibtex

@article{710732469d0a4e51b6e7719fd0723090,
title = "Cyanotic congenital heart disease and atherosclerosis",
abstract = "Improved treatment options in paediatric cardiology and congenital heart surgery have resulted in an ageing population of patients with cyanotic congenital heart disease (CCHD). The risk of acquired heart disease such as atherosclerosis increases with age.Previous studies have speculated whether patients with CCHD are protected against atherosclerosis. Results have shown that the coronary arteries of patients with CCHD are free from plaques and stenosis. Decreased carotid intima-media thickness and low total plasma cholesterol may indicate a reduced risk of later development of atherosclerosis. However, the evidence is still sparse and questionable, and a reasonable explanation for the decreased risk of developing atherosclerosis in patients with CCHD is still missing.This review provides an overview of what is known about the prevalence and potential causes of the reduced risk of atherosclerosis in patients with CCHD.",
keywords = "Atherosclerosis, Global Health, Heart Defects, Congenital, Humans, Prevalence, Journal Article, Review",
author = "Tarp, {Julie Bjerre} and Jensen, {Annette Schophuus} and Thomas Engstr{\o}m and Niels-Henrik Holstein-Rathlou and Lars S{\o}ndergaard",
note = "{\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.",
year = "2017",
month = jun,
doi = "10.1136/heartjnl-2016-311012",
language = "English",
volume = "103",
pages = "897--900",
journal = "Heart",
issn = "1355-6037",
publisher = "B M J Group",

}

RIS

TY - JOUR

T1 - Cyanotic congenital heart disease and atherosclerosis

AU - Tarp, Julie Bjerre

AU - Jensen, Annette Schophuus

AU - Engstrøm, Thomas

AU - Holstein-Rathlou, Niels-Henrik

AU - Søndergaard, Lars

N1 - © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

PY - 2017/6

Y1 - 2017/6

N2 - Improved treatment options in paediatric cardiology and congenital heart surgery have resulted in an ageing population of patients with cyanotic congenital heart disease (CCHD). The risk of acquired heart disease such as atherosclerosis increases with age.Previous studies have speculated whether patients with CCHD are protected against atherosclerosis. Results have shown that the coronary arteries of patients with CCHD are free from plaques and stenosis. Decreased carotid intima-media thickness and low total plasma cholesterol may indicate a reduced risk of later development of atherosclerosis. However, the evidence is still sparse and questionable, and a reasonable explanation for the decreased risk of developing atherosclerosis in patients with CCHD is still missing.This review provides an overview of what is known about the prevalence and potential causes of the reduced risk of atherosclerosis in patients with CCHD.

AB - Improved treatment options in paediatric cardiology and congenital heart surgery have resulted in an ageing population of patients with cyanotic congenital heart disease (CCHD). The risk of acquired heart disease such as atherosclerosis increases with age.Previous studies have speculated whether patients with CCHD are protected against atherosclerosis. Results have shown that the coronary arteries of patients with CCHD are free from plaques and stenosis. Decreased carotid intima-media thickness and low total plasma cholesterol may indicate a reduced risk of later development of atherosclerosis. However, the evidence is still sparse and questionable, and a reasonable explanation for the decreased risk of developing atherosclerosis in patients with CCHD is still missing.This review provides an overview of what is known about the prevalence and potential causes of the reduced risk of atherosclerosis in patients with CCHD.

KW - Atherosclerosis

KW - Global Health

KW - Heart Defects, Congenital

KW - Humans

KW - Prevalence

KW - Journal Article

KW - Review

U2 - 10.1136/heartjnl-2016-311012

DO - 10.1136/heartjnl-2016-311012

M3 - Review

C2 - 28259844

VL - 103

SP - 897

EP - 900

JO - Heart

JF - Heart

SN - 1355-6037

ER -

ID: 188159366